Invitae Common Hereditary Cancers Panel
Sep 2023
914d
Invitae Corporation
1
Total
0
Cleared
1
Denied
Invitae Corporation — FDA 510(k) Submissions
Invitae Corporation has submitted 1 FDA 510(k) premarket notifications since 2023, of which 0 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System. . Use the specialty filter in the sidebar to narrow results.
1 devices